Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

26 Sep 2006 07:03

Cello Group plc26 September 2006 26 September 2006 CELLO ACQUIRES STRATEGY & RESEARCH CONSULTANCY SMT Cello Group plc ("Cello", AIM: CLL), the research and data led marketingservices group, has acquired SMT Consulting Limited ("SMT"), a leading strategyand research consultancy specialising in the fast growing market of business andcompetitive intelligence. Initial consideration consists of up to £6.2 millionwith further performance related consideration of up to £8.8 million. SMT's client base includes around 20% of the FTSE 100 companies and a number ofFortune 500 corporations in the areas of financial services, nuclear &utilities, telecoms and FMCG. It is based in Oxford, employs approximately 35people and also has an office in Shenzhen, China. The initial consideration consists of up to £6.2 million of which £4.2 millionis payable in cash and the balance satisfied by the issue of 1,542,480 newordinary shares. In addition, there are further performance related paymentsover the period to 31 December 2010. These payments are in a mixture of loannotes and new ordinary shares at Cello's discretion, with a maximum shareelement of 75%. In order to finance the cash element of the acquisition, Cello has entered intoa new £12 million committed three year banking facility. Following thetransaction, Cello has net debt of approximately £2 million. For the year to 30 April 2006, SMT had a turnover of £3.4 million and normalisedprofits before tax of £0.8 million. Net assets at 30 April 2006 were £0.7million including cash of £0.5 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 29September 2006. Kevin Steeds, Cello Group's Chairman, said: "SMT is an exciting addition to the Cello Group, further strengthening ourupstream research and consulting offer. With its impressive client franchise inthe UK and Asia, SMT also helps accelerate the development of our internationaloffering." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8461 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello Group plc is a research and data led marketing services group that listedon AIM in November 2004. The Group's strategy is to create value for shareholders by building a portfolioof companies around three specialist platforms, each operating within adifferent niche of the marketing services sector: market research and planning,brand strategy and consultancy, and direct marketing, digital and databasemanagement. Each of Cello's three platforms has significant organic and acquisitive growthpotential; blue chip client relationships with a history of client loyalty;experienced, high quality management teams; and a track record of profitability. Cello Planning and Research * Insight Research Group - London, New York and Basel Insight is a specialist healthcare market research business that offers a broadrange of quantitative and qualitative research based solutions. Its clientsinclude GlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals,NovoNordisk, Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp andDohme. Insight recently acquired FML, a leading field force company. * Leapfrog Research and Planning - Windsor and New York Leapfrog is a leading consumer market research and planning consultancy offeringqualitative and quantitative research in the UK and internationally. It actsfor a number of blue chip clients including Tesco, GSK, BBC, Scottish Courage,Toyota, AA, RHM and Wyeth. * RS Consulting - London RS Consulting is a quantitative market research and business consultancy. Basedin London, the company employs approx 80 people across its three subsidiaries.Major clients include hp, Xerox, Sony, FedEx, Department of Work & Pensions,Cisco Systems, AXA, Yell, RBS, AON and BUPA. Cello Brand Consulting * Leith - Edinburgh and London Leith is the largest and most successful branding agency in Scotland. Theagency has been voted Scottish Agency of the Year for the last five years.Leith opened a London office in 2000 which has recently been integrated withFarm. Leith's major clients include Irn Bru, Scottish Executive, Standard LifeBank, Standard Life, Smile, ICI, FT and Goodfellas Pizza. * The Value Engineers - Beaconsfield TVE is a leading strategic brand consultancy focused on four core disciplines;branding, strategy, insight and innovation. Clients include Unilever,Carlsberg, Diageo, Sony Ericsson, ICI, Visa, BP, T-Mobile and Britvic. * TMI - Redditch Formed in 1978 TMI UK employs some 60 staff and is a leading provider oforganisational development and consultancy solutions to a range of blue chipclients including Toyota, hp, Metronet, Marks and Spencer, the Foreign andCommonwealth Office, National Express Group and Serco Solutions. Cello Response * Target Group - Cheltenham and Cirencester Target is the leading direct and database marketing consultancy specialising inthe "not-for-profit" and charity sector. The agency works for five of the top20 charities in the UK. Target is expanding into the "grey sector" of productsand services for older people for clients such as National Trust, Saga andWhich? Limited. Target has a leading database subsidiary, Talking Numbers and asuccessful print management operation, Target Direct Print. * Navigator Responsive Advertising - Edinburgh Navigator Responsive Advertising, Scotland's leading direct marketing agency,provides responsive communication solutions for a wide range of clientsincluding HBOS Group, De Vere Resort Ownership, ScottishPower, Abbey and RemyMartin. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jun 20077:01 amRNSDirector/PDMR Shareholding
28th Jun 20077:01 amRNSDirectorate Change
8th Jun 20077:01 amRNSAcquisition
22nd May 20071:00 pmRNSAGM Statement
16th May 20079:43 amRNSShare Option Grants
1st May 20074:15 pmRNSAnnual Report and Accounts
1st May 20074:13 pmRNSShare Option Grants
27th Apr 200712:41 pmRNSDirector/PDMR Shareholding
26th Apr 20077:01 amRNSInvestment
10th Apr 20079:44 amRNSTotal voting rights update
2nd Apr 20073:48 pmRNSDirector/PDMR Shareholding
30th Mar 20077:01 amRNSAcquisition
29th Mar 20072:07 pmRNSHolding(s) in Company
20th Mar 20077:01 amRNSFinal Results
9th Mar 20071:18 pmRNSHolding(s) in Company
28th Feb 20074:53 pmRNSHolding(s) in Company
19th Feb 200711:14 amRNSNotice of Results
2nd Feb 20073:05 pmRNSTotal Voting Rights
29th Jan 20077:01 amRNSAcquisition
19th Jan 20073:19 pmRNSHolding(s) in Company
11th Jan 20077:01 amRNSPre Close Trading Statement
15th Dec 20069:01 amRNSDirector/PDMR Shareholding
12th Dec 20069:00 amRNSTotal Voting Rights
30th Nov 20063:56 pmRNSHolding(s) in Company
13th Nov 200612:48 pmRNSAnalyst/Investor Presentation
5th Oct 20065:10 pmRNSNotifiable Interest
4th Oct 20063:53 pmRNSHolding(s) in Company
26th Sep 20067:03 amRNSAcquisition
11th Sep 20063:58 pmRNSHolding(s) in Company
5th Sep 20067:02 amRNSInvestment in Digital Agency
5th Sep 20067:02 amRNSInterim Results
17th Aug 20069:54 amRNSNotice of Results
26th Jul 20062:17 pmRNSAdditional Listing
3rd Jul 200611:53 amRNSAdditional Listing
3rd Jul 20067:01 amRNSPre Close Trading Statement
3rd Jul 20067:01 amRNSControlling Stake
26th Jun 20063:23 pmRNSInvest in brand consulting op
26th Jun 20067:19 amRNSAcquisition
21st Jun 200612:15 pmRNSAnnual Report and Accounts
19th Jun 20063:22 pmRNSMajor Interest in Shares
23rd May 200612:58 pmRNSAGM Statement
27th Mar 20065:46 pmRNSMajor Interest in Shares
27th Mar 20065:05 pmRNSMajor Interests in Shares
21st Mar 20063:39 pmRNSHolding(s) in Company
16th Mar 20067:00 amRNSPerformance Share Option Plan
15th Mar 20067:01 amRNSDirector/PDMR Shareholding
14th Mar 20067:05 amRNSShare Option Plan
14th Mar 20067:02 amRNSFinal Results
20th Feb 20065:19 pmRNSNotice of Results
25th Jan 20063:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.